There is a need to investigate processes that enable sludge re-use while enhancing sewage treatment efficiency. Mechanically disintegrated thickened surplus activated sludge (SAS) and fermented primary sludge were compared for their capacity to produce a carbon source suitable for BNR by completing nutrient removal predictive tests. Mechanically disintegration of SAS using a deflaker enhanced volatile fatty acids (VFAs) content from 92 to 374 mg l(-1) (4.1-fold increase). In comparison, primary sludge fermentation increased the VFAs content from 3.5 g l(-1) to a final concentration of 8.7 g l(-1) (2.5-fold increase). The carbon source obtained from disintegration and fermentation treatments improved phosphate (PO(4)-P) release and denitrification by up to 0.04 mg NO(3)-Ng(-1)VSS min(-1) and 0.031 mg PO(4)-Pg(-1)VSS min(-1), respectively, in comparison to acetate (0.023 mg NO(3)-Ng(-1)VSS min(-1)and 0.010 mg PO(4)-Pg(-1)VSS min(-1)). Overall, both types of sludge were suitable for BNR but disintegrated SAS displayed lower carbon to nutrient ratios of 8 for SCOD:PO(4)-P and 9 for SCOD:NO(3)-N. On the other hand, SAS increased the concentration of PO(4)-P in the settled sewage by a further 0.97 g PO(4)-P kg(-1)SCOD indicating its potential negative impact towards nutrient recycling in the BNR process.

Thyroid carcinoma is the most common endocrine malignancy in dogs. Thyroidectomy and radiation therapy control local disease, yet are not always feasible, and efficacious medical therapies need to be identified. Toceranib phosphate has been reported to provide clinical benefit (CB) in dogs with thyroid carcinoma, while its role in treatment-naïve thyroid tumours has not been well-described. The objective of this study was to describe the use of toceranib in the management of thyroid carcinomas in dogs in both the naïve-disease and prior therapy-settings. A medical record search identified 42 dogs diagnosed with thyroid carcinoma and treated with toceranib, of which 26 and 16 dogs were in settings of naïve-disease and after prior therapy, respectively. Twenty-three (88.4%) and twelve (75%) dogs experienced CB in the naïve and prior therapy settings, respectively. The median [95% confidence interval] progression free interval (PFI) for dogs in the naïve and prior therapy settings were 206 [106,740] and 1015 [92,1015] days, respectively. The median overall survival time (OST) for dogs in the naïve and prior therapy settings were 563 [246,916] and 1082 [289,1894] days, respectively. Overall, the data provided no evidence for differences in overall PFI (P > .20) or OST (P = .15) between settings. However, when asymptomatic at the time of diagnosis, dogs in the naïve setting showed poorer survival prognosis (estimated hazard ratio 17.2 [1.8, 163]) relative to dogs in the prior therapy setting. This study characterizes PFI, OST and CB with minimal AE in dogs with thyroid carcinoma treated with toceranib in both the naïve and prior therapy settings.

The ability of selected bacteria: Myxococcus xanthus, Bacillus pumilus, Halobacterium salinarum, and Brevibacterium antiquum to produce phosphorus bio‐mineral in settled wastewater and sludge dewatering centrifuge liquors was investigated. B. pumilus and B. antiquum were capable of growing and producing bio‐minerals identified as struvite that reached up to 250 µm in size within ten days. This study opens a completely new route to remove and recover phosphorus as struvite from wastewater, with advantages such as being able to use streams with variable phosphorus concentrations of (7–30 mg/L) and no need for external chemicals.

It is proposed that anaerobic treatment of municipal wastewater in temperate climates is attainable through the fortification of wastewater with primary sewage sludge to enhance the chemical oxygen demand (COD). Three bench-scale up-flow anaerobic sludge blanket (UASB) bioreactors (0.5 L) were operated to provide a preliminary verification of this approach. Mass and energy balances were modelled using the GPS-X (COST model, population equivalent of 118,500) to determine the energy balance of the primary sludge wastewater fortification process flowsheet in comparison with conventional aerobic secondary treatment with activated sludge. The addition of 5% primary sludge by volume to crude wastewater pretreated with ultrasound resulted in an increase in total COD from 536 mg L(-1) to 2300 mg L(-1). A COD removal of 86% +/- 8% and methane production of 400 mL L(-1) d(-1) were achieved in the reactor that was supplied with this primary sludge fortified wastewater. In comparison a COD reduction of 77% +/- 8% and 40 mL L(-1) d(-1) of methane were observed in the reactor which was supplied with crude wastewater only, and a 79% +/- 8% COD removal and 156 mL L(-1) d(-1) of methane were observed in UASB2, which was supplied with crude wastewater pretreated with ultrasound. The modelled energy balance for the fortified wastewater treatment process flowsheet was -305 kWh d(-1) compared with -937 kWh d(-1) in the aerobic flowsheet, corresponding to an energy saving of 67%.

The current standard method used for measuring soluble phosphate in environmental water samples is based on a colourimetric approach, developed in the early 1960s. In order to provide an alternative, label free sensing solution, a molecularly imprinted polymer (MIP) was designed to function as a phosphate receptor. A combination of functional monomer (N-allylthiourea), cross-linker and monomer/template ratios were optimised in order to maximise the binding capacity for phosphate. When produced in membrane format, the MIP's ability to produce a reversible change in conductance in the presence of phosphate was explored for fabrication of a sensor which was able to selectively detect the presence of phosphate compared to sulphate, nitrate and chloride. In wastewater samples the sensor had a limit of detection of 0.16 mg P/l, and a linear range between 0.66 and 8 mg P/l. This is below the minimum monitoring level (1 mg P/l) as required by current legislation for wastewater discharges, making the sensor as developed promising for direct quantification of phosphate in environmental monitoring applications.

It is estimated that up to 342 wastewater treatment plants (Wwtps) in England and Wales will require a phosphorus (P) consent by 2010. Although biological P removal is considered to be the most sustainable option for P removal, it has always been problematic for plants that remove both nitrogen and P due to the inadequate concentration of organic material during wet periods. Two biological nutrient removal (BNR) configurations, the Johannesburg (JHB) process and a combined JHB and five-stage Bardenpho process, were evaluated over a period of 2 years to assess the impact of sewage strength on bio-P removal. The JHB achieved an average effluent total phosphorus (TP) of 2.4 mg/L and the combined JHB and five-stage process averaged 1.4 mg/L effluent TP. The major problems affecting the performance of both configurations were: dissolved oxygen (DO) in the recycled mixed liquor, nitrate in the return activated sludge (RAS) and low influent biological oxygen demand (BOD) concentrations. Acetate dosing proved successful as a source of volatile fatty acids (VFAs) in the anaerobic zone during periods of low-strength sewage. An acetate dosing strategy based on the influent flow rate to the plant was found to be a simple and effective technique that ensured that a consent of o1 mg TP/L could be met.

Phosphate detection in water samples is still completed using colorimetric standard methods, which have a number of disadvantages, to such as being time consuming, requiring filtration, a number of different reagents, frequent calibration and proper disposal of waste chemicals generated. Hence, a simple cost effective analytical method and instrumentation is highly desirable to aid the optimisation of treatment processes and assist the water industry in their efforts to comply with stringent regulations such as the EU's Water Framework Directive. A sensor based on molecular imprinted polymer (MIP) and a conductance transducer was developed for direct and label-free detection of phosphate in water. The sensor was able to measure the presence of phosphate in wastewater samples with good reproducibility, a linear range of 0.66-8 mg P L(-1) and a lower detection limit of 0.16 mg P L(-1). The sensor was further tested to measure phosphate concentrations in unfiltered field samples such as domestic wastewater treatment influent and river water and demonstrated a close correlation with reference measurements. The phosphate MIP sensor offers a way forward as either a handheld sensor for use in the field, or as a potential solution for remote, continuous monitoring of phosphate.

MLN4924 (pevonedistat) is a potent and selective NEDD8‐activating enzyme (NAE) inhibitor. The NEDD8‐regulated neddylation system is responsible for the regulated degradation of intracellular proteins with important cellular functions in cancer cell growth, apoptosis, angiogenesis and metastasis. In human melanoma, inhibition of NAE results in induction of DNA re‐replication, S phase cell cycle arrest, DNA damage and apoptosis. The study aimed to assess the anti‐cancer effect of MLN4924 on canine malignant melanoma cell lines and patient samples and to elucidate the underlying mechanisms. Canine melanoma cell lines and primary patient samples were evaluated for cell viability after incubation with varying concentrations of MLN4924 or dimethyl sulfoxide. Apoptosis, cell proliferation and senescence assays were performed to address underlying mechanisms of MLN4924‐mediated anti‐tumour effects. Gene expression of seven previously identified deregulated genes in human melanoma was compared in sensitive vs resistant samples. MLN4924 treatment significantly reduced the viability of canine melanoma cell lines and primary samples in a dose‐ and time‐dependent manners. MLN4924 promoted cell apoptosis and inhibited cell growth through induction of DNA re‐replication and cell senescence. While the majority of canine melanoma samples demonstrated sensitivity at nanomolar ranges, some samples were resistant to the treatment. Modulation of P21 levels correlated with canine melanoma cell sensitivity. These results provided justification for further exploration of MLN4924 as a treatment of canine melanoma.